Otitis media
Otitis media is an inflammatory disease involving all or part of the structure of the middle ear (including the Eustachian tube, tympanic cavity, tympanic sinus and mastoid air cell). Most of them are non-specific inflammations, especially in children. They can be divided into two categories: non-suppurative and suppurative. Non-suppurative ones include secretory otitis media and barotraumatic otitis media; suppurative ones are divided into acute and chronic ones. Specific inflammation is rare, such as tuberculous otitis media. Common ones include secretory otitis media, acute suppurative otitis media, cholesteatoma otitis media and barotraumatic otitis media.
Related Drugs
Trimethoprim-sulfamethoxazole tablets
Indication: It is mainly used for urinary tract infections, intestinal infections, acute attacks of chronic bronchitis in adults, acute otitis media, etc. caused by bacteria sensitive to this product.
Manufacturer:
Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY
Trimethoprim-sulfamethoxazole tablets
Indication: It is mainly used for urinary tract infections, intestinal infections, acute attacks of chronic bronchitis in adults, acute otitis media, etc. caused by bacteria sensitive to this product.
Manufacturer:
Harbin Taihua Pharmaceutical Co., Ltd.
Trimethoprim-sulfamethoxazole tablets
Indication: It is mainly used for urinary tract infections, intestinal infections, acute attacks of chronic bronchitis in adults, acute otitis media, etc. caused by bacteria sensitive to this product.
Manufacturer:
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Trimethoprim-sulfamethoxazole tablets
Indication: It is mainly used for urinary tract infections, intestinal infections, acute attacks of chronic bronchitis in adults, acute otitis media, etc. caused by bacteria sensitive to this product.
Manufacturer:
HUAZHONG Pharmaceutical Co., Ltd.
Sulfadiazine Tablets
Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.
Manufacturer:
Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.
Sulfadiazine Tablets
Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.
Sulfadiazine Tablets
Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.
Manufacturer:
Sunflower Pharmaceutical Group Hubei Wudang Co., Ltd.
Sulfadiazine Tablets
Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.
Manufacturer:
Hubei Wudang Pharmaceutical Co., Ltd.
Sulfadiazine Tablets
Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.
Manufacturer:
Hubei Zhongjia Pharmaceutical Co., Ltd.
Sulfadiazine Tablets
Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.
Manufacturer:
Mayinglong Pharmaceutical Group Co., Ltd.